What is he best known for?
The fields of study he is best known for:
His primary areas of study are Prostate cancer, Genetics, Genome-wide association study, Single-nucleotide polymorphism and Cancer.
His Prostate cancer study is concerned with Internal medicine in general.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Gynecology, with regards to Gene mutation, Prostate biopsy, Prostate cancer screening and Prostate-specific antigen.
His Genome-wide association study research incorporates themes from Linkage disequilibrium, Genetic association, Locus and Genetic epidemiology.
He has included themes like Odds ratio, Genotyping, Case-control study and Allele in his Single-nucleotide polymorphism study.
His Cancer research incorporates elements of DNA Mutational Analysis and Immunology.
His most cited work include:
- The evolutionary history of lethal metastatic prostate cancer. (787 citations)
- Multiple newly identified loci associated with prostate cancer susceptibility. (754 citations)
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants (546 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Genome-wide association study and Genetics.
His biological study spans a wide range of topics, including Single-nucleotide polymorphism, Genotype, Case-control study and Prostate.
His study in Single-nucleotide polymorphism is interdisciplinary in nature, drawing from both Genotyping, Genetic variation and Bioinformatics.
As a member of one scientific family, Zsofia Kote-Jarai mostly works in the field of Oncology, focusing on Germline and, on occasion, DNA repair.
His research investigates the connection between Genome-wide association study and topics such as Genetic association that intersect with problems in Heritability and 1000 Genomes Project.
His study looks at the relationship between Cancer and fields such as Cancer research, as well as how they intersect with chemical problems.
He most often published in these fields:
- Prostate cancer (69.17%)
- Internal medicine (48.62%)
- Oncology (45.06%)
What were the highlights of his more recent work (between 2017-2021)?
- Prostate cancer (69.17%)
- Internal medicine (48.62%)
- Oncology (45.06%)
In recent papers he was focusing on the following fields of study:
Zsofia Kote-Jarai mainly focuses on Prostate cancer, Internal medicine, Oncology, Genome-wide association study and Genetic association.
His Prostate cancer research is multidisciplinary, relying on both Prostate, Gene, DNA repair, Hazard ratio and Single-nucleotide polymorphism.
The study incorporates disciplines such as Proportional hazards model and Genetic variation in addition to Single-nucleotide polymorphism.
The various areas that Zsofia Kote-Jarai examines in his Oncology study include Germline mutation, Genetic predisposition, Relative risk, Germline and Stage.
His research on Genome-wide association study is centered around Genetics and Genotype.
His studies in Genetic association integrate themes in fields like Imputation, Breast cancer and Gene expression.
Between 2017 and 2021, his most popular works were:
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)
- Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets (100 citations)
- Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts (80 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Zsofia Kote-Jarai mostly deals with Prostate cancer, Genome-wide association study, Internal medicine, Oncology and Genetic association.
His Prostate cancer study integrates concerns from other disciplines, such as Cancer research, Prostate, Disease and Gene, DNA repair.
Genetics covers he research in Genome-wide association study.
In the field of Internal medicine, his study on Relative risk, Cancer and Prostate cancer screening overlaps with subjects such as Risk assessment.
His studies deal with areas such as Prostate-specific antigen, Germline mutation and Genotype as well as Oncology.
His Genetic association study combines topics from a wide range of disciplines, such as Imputation, Odds ratio, Computational biology and SNP.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
